C12N 2500/84
From mammals
Official title: from mammals
C12N2500/84 (From mammals) appears on 293 US grants and 517 published applications in this corpus.
Search patents in C12N- Granted patents
- 293
- Published applications
- 517
- Assignees
- 362
- Inventors
- 1,148
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 4 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 0 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 6 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 0 |
| 2002 | 3 | 4 |
| 2003 | 3 | 5 |
| 2004 | 0 | 5 |
| 2005 | 1 | 9 |
| 2006 | 4 | 8 |
| 2007 | 1 | 14 |
| 2008 | 3 | 8 |
| 2009 | 5 | 15 |
| 2010 | 7 | 17 |
| 2011 | 6 | 25 |
| 2012 | 10 | 18 |
| 2013 | 10 | 14 |
| 2014 | 7 | 21 |
| 2015 | 15 | 30 |
| 2016 | 17 | 26 |
| 2017 | 17 | 30 |
| 2018 | 16 | 32 |
| 2019 | 22 | 28 |
| 2020 | 12 | 20 |
| 2021 | 14 | 31 |
| 2022 | 11 | 28 |
| 2023 | 9 | 29 |
| 2024 | 13 | 45 |
| 2025 | 21 | 29 |
| 2026 | 16 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Method for manufacturing mitochondria-rich plasma22 Sep 2026US 12,741,068 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- Production of a probiotic composition25 Aug 2026US 12,714,731 B2Blis Technologies Limited
- Microbial inoculant for high-speed humification of organic waste and preparation method thereof7 Jul 2026US 12,673,904 B2Tongji University
- Myogenin-expressing fibroblast-like cell (MEFLC) line and construction method and use thereof7 Jul 2026US 12,674,140 B2Foshan Zhongke Rhythm Biotech Co.,Ltd.
- Production of a probiotic composition8 Oct 2026US 2026/0306558 A1Blis Technologies Limited
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Process for preparation of human umbilical cord blood plasma and culture media for tissue regeneration27 Aug 2026US 2026/0250637 A1Iceta - Instituto De CiêNcias, Tecnologias E Agroambiente Da Universidade Do Porto
- Cardiac cell compositions, uses thereof, and methods for treatment of heart disease16 Jul 2026US 2026/0199399 A1MaineHealth
- Use of chick embryo extract in promoting synthesis of lactoferrin by mammary epithelial cells16 Jul 2026US 2026/0201326 A1Beijing Sanyuan Foods Co., Ltd.
Most cited
By later US patents
- Serum-free cell culture medium and process for making same430US 4,560,655 AImmunex Corporation · 1985
- Reconstituted basement membrane complex with biological activity212US 4,829,000 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1989
- Submucosa extracts111US 6,375,989 B1Purdue Research Foundation · 2002
- Tissue culture medium81US 4,533,634 AAMF Incorporated · 1985
- Synergistic composition for endothelial cell growth80US 5,073,492 AThe Johns Hopkins University · 1991